Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Hypertension Monitoring in Glioma Patients Treated With Bevacizumab

This study has been terminated.
(Problems with enrollement of patients, less patients than expected)
Sponsor:
Information provided by (Responsible Party):
University of Zurich
ClinicalTrials.gov Identifier:
NCT01046279
First received: January 8, 2010
Last updated: June 12, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2012
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)